DOCSLIB.ORG

Functional Role of Mst1/Mst2 in Embryonic Stem Cell Differentiation

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Functional Role of Mst1/Mst2 in Embryonic Stem Cell Differentiation Functional Role of Mst1/Mst2 in Embryonic Stem Cell Differentiation Peng Li1, Ying Chen2, Kinglun Kingston Mak3,4,5, Chun Kwok Wong1,4, Chi Chiu Wang2,3,4,6, Ping Yuan1,2,3,4* 1 Department of Chemical Pathology, the Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, New Territories, Hong Kong SAR, China, 2 Li Ka Shing Institute of Health Sciences, the Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, New Territories, Hong Kong SAR, China, 3 School of Biomedical Sciences, the Chinese University of Hong Kong, Shatin, New Territories, Hong Kong SAR, China, 4 CUHK Shenzhen Research Institute, the Chinese University of Hong Kong, Shenzhen, Guangdong, China, 5 Key Laboratories for Regenerative Medicine, Ministry of Education, the Chinese University of Hong Kong, Shatin, New Territories, Hong Kong SAR, China, 6 Fetal Medicine Unit, Department of Obstetrics and Gynaecology, the Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, New Territories, Hong Kong SAR, China Abstract The Hippo pathway is an evolutionary conserved pathway that involves cell proliferation, differentiation, apoptosis and organ size regulation. Mst1 and Mst2 are central components of this pathway that are essential for embryonic development, though their role in controlling embryonic stem cells (ES cells) has yet to be exploited. To further understand the Mst1/Mst2 function in ES cell pluripotency and differentiation, we derived Mst1/Mst2 double knockout (Mst-/-) ES cells to completely perturb Hippo signaling. We found that Mst-/- ES cells express higher level of Nanog than wild type ES cells and show differentiation resistance after LIF withdrawal. They also proliferate faster than wild type ES cells. Although Mst-/- ES cells can form embryoid bodies (EBs), their differentiation into tissues of three germ layers is distorted. Intriguingly, Mst-/- ES cells are unable to form teratoma. Mst-/- ES cells can differentiate into mesoderm lineage, but further differentiation to cardiac lineage cells is significantly affected. Microarray analysis revealed that ligands of non-canonical Wnt signaling, which is critical for cardiac progenitor specification, are significantly repressed in Mst-/- EBs. Taken together our results showed that Mst1/Mst2 are required for proper cardiac lineage cell development and teratoma formation. Citation: Li P, Chen Y, Mak KK, Wong CK, Wang CC, et al. (2013) Functional Role of Mst1/Mst2 in Embryonic Stem Cell Differentiation. PLoS ONE 8(11): e79867. doi:10.1371/journal.pone.0079867 Editor: Robert Dettman, Northwestern University, United States of America Received May 23, 2013; Accepted September 26, 2013; Published November 5, 2013 Copyright: © 2013 Li et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Funding: The authors have no support or funding to report. Competing interests: The authors have declared that no competing interests exist. * E-mail: [email protected] Introduction pathway promotes apoptosis and inhibits tumorigenesis in mammals [7-10]. The Hippo pathway was first discovered in Drosophila. Mst1 and Mst2 (Mammalian sterile 20-like kinases 1 and 2) Through genetic mosaic screens, core components of the are the core components of the Hippo pathway. They play Hippo pathway, such as Warts (Wts), Hippo (Hpo) and important roles in early embryonic development, cell Salvador (Sav) were identified as tumor-suppressor genes proliferation, apoptosis and organ size control. Mst1 null mice [1-4]. These components restrict cell proliferation and promote are viable and fertile but have a reduced number of mature apoptosis by repressing the downstream effector Yokie (Yki) in naive T cells, while Mst2 null mice are also fertile but exhibit no Drosophila. Depletion of core components of the Hippo developmental or immunological defects [11]. However, depletion of both Mst1 and Mst2 resulted in embryonic lethality pathway or overexpression of Yki results in enhanced cell at embryonic day 8.5, suggesting redundant roles of Mst1 and proliferation and reduced apoptosis respectively [5]. This Mst2 [12]. One functional copy of either Mst1 or Mst2 is pathway is highly conserved in mammals. Serine/threonine necessary and sufficient for early embryonic development kinases Mst1/Mst2 and Lats1/Lats2 in mammals are homologs [11,13]. of Hippo and Wts in Drosophila respectively. Together with an Like other components of the Hippo pathway that promote adaptor protein hMob1, they transmit signals to downstream apoptosis, Mst1/Mst2 are pro-apoptotic kinases [14,15]. Under effectors [6]. Through inhibiting the transcriptional co-activators oxidative stress, Mst1/Mst2 activate transcription factor Foxo and oncoproteins Yap (Yes kinase-associated protein) and Taz and promote neuronal cell death [16,17]. Heart specific (transcriptional coactivator with PDZ-binding motif), the Hippo expression of Mst1 leads to dilated cardiomyopathy with PLOS ONE | www.plosone.org 1 November 2013 | Volume 8 | Issue 11 | e79867 Differentiation Distortion of Mst-/- ES Cells reduction in cell density in heart [18]. Liver specific removal of further address this question, we generated Mst-/- ES cells Mst1/Mst2 in newborn mice results in liver enlargement and from Mst1 and Mst2 mutant mice [12]. We found that the formation of hepatocellular carcinoma and cholangiocarcinoma phosphorylation level of Yap was decreased in Mst-/- ES cells, [12,19-21]. Similarly, in mouse intestines and pancreas, whilst the pluripotency marker Nanog was increased inactivation of Mst1/Mst2 leads to intestinal stem cell significantly compared to wild type ES cells. Mst-/- ES cells overproliferation, colonic tumorigenesis and pancreas also showed differentiation resistance for a relatively longer overgrowth [22-24], suggesting important roles of Mst1/Mst2 in time compared to wild type ES cells under differentiation organ size control and tumorigenesis. conditions. Consistent with the developmental defects of Mst1/ Mst1/Mst2 activate Lats1 and Lats2 by phosphorylation, and Mst2 double knockout mice, Mst-/- ES cells showed lineage in turn phosphorylate Yap and inhibit it from translocating into development distortion during embryoid body (EB) formation the nucleus [25]. Unphosphorylated Yap can be translocated and obvious defects to differentiation to cardiac progenitor into the nucleus to activate TEA-domain (TEAD) family cells. Microarray analysis revealed that the non-canonical Wnt members. The Yap/Taz-Tead complex further activates pathway ligands Wnt2b and Wnt5a, which are critical for proliferation by a genome wide transcriptional program [26-28]. cardiac progenitor cell differentiation, were significantly Ectopic expression of Yap in mammalian cells leads to a downregulated in Mst-/- EBs. Unlike wild type ES cells, Mst-/- phenotype resembling that from ablation of core components of ES cells could not form teratoma after subcutaneously injected the Hippo pathway. Similar to the simultaneous removal of into nude mice. Taken together, our data suggest that Mst1/ Mst1/Mst2, overexpression of Yap in mice results in a dramatic Mst2 are required for teratoma formation. Their functions are increase of liver mass with subsequent tumor formation. In also critical for proper cardiac lineage cell formation. addition previous research reveals that Yap is an important pluripotent factor. Expression of Yap enhances reprogramming Results of differentiated cells to induced pluripotent stem (iPS) cells [26,29,30]. In adults Yap is enriched in organs such as the Derivation of mouse Mst-/- embryonic stem cells small intestine and the developing brain and its expression is Based on the schematics of null alleles of Mst1 and Mst2 highly restricted to the progenitor or stem compartments, generated in a previous study [12], we crossed the Mst1+/- whereas in other tissues, such as skin and skeletal muscle, the Mst2-/- male and female mice, harvested the E3.5 embryos and expression of Yap is gradually decreased with regard to derived ES cells on MEF feeder (Figure S1A and S1B). These differentiation status [10,26,31,32]. Yap is therefore, a cells were further adapted to form feeder-free ES cell lines stemness gene in mammalian cells, while key components of under the 2i+LIF condition for genotyping. Exon 4 and 5 which Hippo pathway such as Mst1/Mst2, function to constrain this encode kinase domain are deleted in Mst1 knockout, while stemness gene in restricted compartments. exon 5 and 6 which encode kinase domain are deleted in Mst2 Mst1/Mst2 double knockout mice die at E8.5 with knockout (Figure S1C). With primers targeted to the adjacent abnormalities in the placenta, vascular patterning and primitive sequence of the deleted regions of Mst1 (exon 4 and 5) and hematopoiesis, suggesting that Mst1/Mst2 are not required for Mst2 (exon 5 and 6), PCR confirmed that respective regions of pluripotent inner cell mass (ICM) formation but are required for Mst1 and Mst2 genomic DNA were deleted in Mst1/Mst2 subsequent organ and tissue development. As an in vitro double knockout (Mst-/-) ES cell lines respectively (Figure 1A). derivative of the pluripotent inner cell mass (ICM), ES cells Two Mst1/Mst2 double knockout lines, Mst-/-1 and Mst-/-2 ES retain the developmental characteristics of ICM and can self- cell lines were selected for further studies (Figure 1A). The renew and differentiate to all three
Load more

Recommended publications
  • Fgf17b and FGF18 Have Different Midbrain Regulatory Properties from Fgf8b Or Activated FGF Receptors Aimin Liu1,2, James Y
    Research article 6175 FGF17b and FGF18 have different midbrain regulatory properties from FGF8b or activated FGF receptors Aimin Liu1,2, James Y. H. Li2, Carrie Bromleigh2, Zhimin Lao2, Lee A. Niswander1 and Alexandra L. Joyner2,* 1Howard Hughes Medical Institute, Developmental Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA 2Howard Hughes Medical Institute and Skirball Institute of Biomolecular Medicine, Departments of Cell Biology, and Physiology and Neuroscience, NYU School of Medicine, New York, NY 10016, USA *Author for correspondence (e-mail: [email protected]) Accepted 28 August 2003 Development 130, 6175-6185 Published by The Company of Biologists 2003 doi:10.1242/dev.00845 Summary Early patterning of the vertebrate midbrain and region in the midbrain, correlating with cerebellum cerebellum is regulated by a mid/hindbrain organizer that development. By contrast, FGF17b and FGF18 mimic produces three fibroblast growth factors (FGF8, FGF17 FGF8a by causing expansion of the midbrain and and FGF18). The mechanism by which each FGF upregulating midbrain gene expression. This result is contributes to patterning the midbrain, and induces a consistent with Fgf17 and Fgf18 being expressed in the cerebellum in rhombomere 1 (r1) is not clear. We and midbrain and not just in r1 as Fgf8 is. Third, analysis of others have found that FGF8b can transform the midbrain gene expression in mouse brain explants with beads soaked into a cerebellum fate, whereas FGF8a can promote in FGF8b or FGF17b showed that the distinct activities of midbrain development. In this study we used a chick FGF17b and FGF8b are not due to differences in the electroporation assay and in vitro mouse brain explant amount of FGF17b protein produced in vivo.
    [Show full text]
  • Fgf8 Is Mutated in Zebrafish Acerebellar
    Development 125, 2381-2395 (1998) 2381 Printed in Great Britain © The Company of Biologists Limited 1998 DEV1265 Fgf8 is mutated in zebrafish acerebellar (ace) mutants and is required for maintenance of midbrain-hindbrain boundary development and somitogenesis Frank Reifers1, Heike Böhli1, Emily C. Walsh2, Phillip H. Crossley2, Didier Y. R. Stainier2 and Michael Brand1,* 1Department of Neurobiology, University of Heidelberg, Im Neuenheimer Feld 364, D-69120 Heidelberg, Germany 2Department of Biochemistry and Biophysics, University of California San Francisco, San Francisco, CA 94143-0554, USA *Author for correspondence (e-mail: [email protected]) Accepted 2 April; published on WWW 3 June 1998 SUMMARY We describe the isolation of zebrafish Fgf8 and its gastrulation, and that Fgf8 functions later during expression during gastrulation, somitogenesis, fin bud and somitogenesis to polarize the midbrain. Fgf8 is also early brain development. By demonstrating genetic linkage expressed in a dorsoventral gradient during gastrulation and by analysing the structure of the Fgf8 gene, we show and ectopically expressed Fgf8 can dorsalize embryos. that acerebellar is a zebrafish Fgf8 mutation that may Nevertheless, acerebellar mutants show only mild inactivate Fgf8 function. Homozygous acerebellar embryos dorsoventral patterning defects. Also, in spite of the lack a cerebellum and the midbrain-hindbrain boundary prominent role suggested for Fgf8 in limb development, the organizer. Fgf8 function is required to maintain, but not pectoral fins are largely unaffected in the mutants. Fgf8 is initiate, expression of Pax2.1 and other marker genes in this therefore required in development of several important area. We show that Fgf8 and Pax2.1 are activated in signaling centers in the zebrafish embryo, but may be adjacent domains that only later become overlapping, and redundant or dispensable for others.
    [Show full text]
  • Different Fgfs Have Distinct Roles in Regulating Neurogenesis After Spinal Cord Injury in Zebrafish Yona Goldshmit1,2, Jean Kitty K
    Goldshmit et al. Neural Development (2018) 13:24 https://doi.org/10.1186/s13064-018-0122-9 RESEARCHARTICLE Open Access Different Fgfs have distinct roles in regulating neurogenesis after spinal cord injury in zebrafish Yona Goldshmit1,2, Jean Kitty K. Y. Tang1, Ashley L. Siegel1, Phong D. Nguyen1, Jan Kaslin1, Peter D. Currie1 and Patricia R. Jusuf1,3* Abstract Background: Despite conserved developmental processes and organization of the vertebrate central nervous system, only some vertebrates including zebrafish can efficiently regenerate neural damage including after spinal cord injury. The mammalian spinal cord shows very limited regeneration and neurogenesis, resulting in permanent life-long functional impairment. Therefore, there is an urgent need to identify the cellular and molecular mechanisms that can drive efficient vertebrate neurogenesis following injury. A key pathway implicated in zebrafish neurogenesis is fibroblast growth factor signaling. Methods: In the present study we investigated the roles of distinctfibroblastgrowthfactormembersandtheir receptors in facilitating different aspects of neural development and regeneration at different timepoints following spinal cord injury. After spinal cord injury in adults and during larval development, loss and/or gain of Fgf signaling was combined with immunohistochemistry, in situ hybridization and transgenes marking motor neuron populations in in vivo zebrafish and in vitro mammalian PC12 cell culture models. Results: Fgf3 drives neurogenesis of Islet1 expressing motor neuron subtypes and mediate axonogenesis in cMet expressing motor neuron subtypes. We also demonstrate that the role of Fgf members are not necessarily simple recapitulating development. During development Fgf2, Fgf3 and Fgf8 mediate neurogenesis of Islet1 expressing neurons and neuronal sprouting of both, Islet1 and cMet expressing motor neurons.
    [Show full text]
  • The Act of Controlling Adult Stem Cell Dynamics: Insights from Animal Models
    biomolecules Review The Act of Controlling Adult Stem Cell Dynamics: Insights from Animal Models Meera Krishnan 1, Sahil Kumar 1, Luis Johnson Kangale 2,3 , Eric Ghigo 3,4 and Prasad Abnave 1,* 1 Regional Centre for Biotechnology, NCR Biotech Science Cluster, 3rd Milestone, Gurgaon-Faridabad Ex-pressway, Faridabad 121001, India; [email protected] (M.K.); [email protected] (S.K.) 2 IRD, AP-HM, SSA, VITROME, Aix-Marseille University, 13385 Marseille, France; [email protected] 3 Institut Hospitalo Universitaire Méditerranée Infection, 13385 Marseille, France; [email protected] 4 TechnoJouvence, 13385 Marseille, France * Correspondence: [email protected] Abstract: Adult stem cells (ASCs) are the undifferentiated cells that possess self-renewal and differ- entiation abilities. They are present in all major organ systems of the body and are uniquely reserved there during development for tissue maintenance during homeostasis, injury, and infection. They do so by promptly modulating the dynamics of proliferation, differentiation, survival, and migration. Any imbalance in these processes may result in regeneration failure or developing cancer. Hence, the dynamics of these various behaviors of ASCs need to always be precisely controlled. Several genetic and epigenetic factors have been demonstrated to be involved in tightly regulating the proliferation, differentiation, and self-renewal of ASCs. Understanding these mechanisms is of great importance, given the role of stem cells in regenerative medicine. Investigations on various animal models have played a significant part in enriching our knowledge and giving In Vivo in-sight into such ASCs regulatory mechanisms. In this review, we have discussed the recent In Vivo studies demonstrating the role of various genetic factors in regulating dynamics of different ASCs viz.
    [Show full text]
  • (12) Patent Application Publication (10) Pub. No.: US 2015/0023954 A1 Wu Et Al
    US 2015 0023954A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2015/0023954 A1 Wu et al. (43) Pub. Date: Jan. 22, 2015 (54) POTENTIATING ANTIBODY-INDUCED GOIN33/574 (2006.01) COMPLEMENT-MEDIATED CYTOTOXCITY A613 L/4745 (2006.01) VAPI3K INHIBITION A613 L/4375 (2006.01) (52) U.S. Cl. (71) Applicant: MEMORIAL SLOAN-KETTERING CPC ....... A6IK39/39558 (2013.01); A61 K3I/4745 CANCER CENTER, New York, NY (2013.01); A61 K39/00II (2013.01); A61 K (US) 39/385 (2013.01); A61K31/4375 (2013.01); A6IK3I/5377 (2013.01); A61K.39/39 (72) Inventors: Xiaohong Wu, Forest Hills, NY (US); (2013.01); GOIN33/57484 (2013.01); CI2O Wolfgang W. Scholz, San Diego, CA I/6886 (2013.01); A61 K 2039/505 (2013.01); (US); Govind Ragupathi, New York, C12O 2600/16 (2013.01); C12O 2600/106 NY (US); Philip O. Livingston, (2013.01); A61K 2039/545 (2013.01) Bluffton, SC (US) USPC .................. 424/133.1; 424/277.1; 424/193.1; 424f1 74.1436/5O1435/7.1 : 506/9:435/7.92: (21) Appl. No.: 14/387,153 s s 435/6.12. 436/94 (22) PCT Filed: Mar. 14, 2013 (57) ABSTRACT (86). PCT No.: PCT/US 13/31278 Methodologies and technologies for potentiating antibody S371 (c)(1), based cancer treatments by increasing complement-mediated (2) Date: Sep. 22, 2014 cell cytotoxicity are disclosed. Further provided are method O O ologies and technologies for overcoming ineffective treat Related U.S. Application Data ments correlated with and/or caused by sub-lytic levels of (60) Provisional application No.
    [Show full text]
  • The Biology of Hepatocellular Carcinoma: Implications for Genomic and Immune Therapies Galina Khemlina1,4*, Sadakatsu Ikeda2,3 and Razelle Kurzrock2
    Khemlina et al. Molecular Cancer (2017) 16:149 DOI 10.1186/s12943-017-0712-x REVIEW Open Access The biology of Hepatocellular carcinoma: implications for genomic and immune therapies Galina Khemlina1,4*, Sadakatsu Ikeda2,3 and Razelle Kurzrock2 Abstract Hepatocellular carcinoma (HCC), the most common type of primary liver cancer, is a leading cause of cancer-related death worldwide. It is highly refractory to most systemic therapies. Recently, significant progress has been made in uncovering genomic alterations in HCC, including potentially targetable aberrations. The most common molecular anomalies in this malignancy are mutations in the TERT promoter, TP53, CTNNB1, AXIN1, ARID1A, CDKN2A and CCND1 genes. PTEN loss at the protein level is also frequent. Genomic portfolios stratify by risk factors as follows: (i) CTNNB1 with alcoholic cirrhosis; and (ii) TP53 with hepatitis B virus-induced cirrhosis. Activating mutations in CTNNB1 and inactivating mutations in AXIN1 both activate WNT signaling. Alterations in this pathway, as well as in TP53 and the cell cycle machinery, and in the PI3K/Akt/mTor axis (the latter activated in the presence of PTEN loss), as well as aberrant angiogenesis and epigenetic anomalies, appear to be major events in HCC. Many of these abnormalities may be pharmacologically tractable. Immunotherapy with checkpoint inhibitors is also emerging as an important treatment option. Indeed, 82% of patients express PD-L1 (immunohistochemistry) and response rates to anti-PD-1 treatment are about 19%, and include about 5% complete remissions as well as durable benefit in some patients. Biomarker-matched trials are still limited in this disease, and many of the genomic alterations in HCC remain challenging to target.
    [Show full text]
  • TABLE S1 Complete Overview of Protocols for Induction of Pscs Into
    TABLE S1 Complete overview of protocols for induction of PSCs into renal lineages Ref 2D/ Cell type Protocol Days Growth factors Outcome Other analyses # 3D hiPSC, hESC, Collagen type I tx murine epidydymal fat pads,ex vivo 54 2D 8 Y27632, AA, CHIR, BMP7 IM miPSC, mESC Matrigel with murine fetal kidney hiPSC, hESC, Suspension,han tx murine epidydymal fat pads,ex vivo 54 2D 20 AA, CHIR, BMP7 IM miPSC, mESC ging drop with murine fetal kidney tx murine epidydymal fat pads,ex vivo 55 hiPSC, hESC Matrigel 2D 14 CHIR, TTNPB/AM580, Y27632 IM with murine fetal kidney Injury, tx murine epidydymal fat 57 hiPSC Suspension 2D 28 AA, CHIR, BMP7, TGF-β1, TTNPB, DMH1 NP pads,spinal cord assay Matrigel,membr 58 mNPC, hESC 3D 7 BPM7, FGF9, Heparin, Y27632, CHIR, LDN, BMP4, IGF1, IGF2 NP Clonal expansion ane filter iMatrix,spinal 59 hiPSC 3D 10 LIF, Y27632, FGF2/FGF9, TGF-α, DAPT, CHIR, BMP7 NP Clonal expansion cord assay iMatrix,spinal 59 murine NP 3D 8-19 LIF, Y27632, FGF2/FGF9, TGF- α, DAPT, CHIR, BMP7 NP Clonal expansion cord assay murine NP, Suspension, 60 3D 7-19 BMP7, FGF2, Heparin, Y27632, LIF NP Nephrotoxicity, injury model human NP membrane filter Suspension, Contractility and permeability assay, ex 61 hiPSC 2D 10 AA, BMP7, RA Pod gelatin vivo with murine fetal kidney Matrigel. 62 hiPSC, hESC fibronectin, 2D < 50 FGF2, AA, WNT3A, BMP4, BMP7, RA, FGF2, HGF or RA + VITD3 Pod collagen type I Matrigel, Contractility and uptake assay,ex vivo 63 hiPSC 2D 13 Y27632, CP21R7, BMP4, RA, BMP7, FGF9, VITD3 Pod collagen type I with murine fetal kidney Collagen
    [Show full text]
  • SAV1 Promotes Hippo Kinase Activation Through Antagonizing the PP2A Phosphatase STRIPAK
    RESEARCH ARTICLE SAV1 promotes Hippo kinase activation through antagonizing the PP2A phosphatase STRIPAK Sung Jun Bae1†, Lisheng Ni1†, Adam Osinski1, Diana R Tomchick2, Chad A Brautigam2,3, Xuelian Luo1,2* 1Department of Pharmacology, University of Texas Southwestern Medical Center, Dallas, United States; 2Department of Biophysics, University of Texas Southwestern Medical Center, Dallas, United States; 3Department of Microbiology, University of Texas Southwestern Medical Center, Dallas, United States Abstract The Hippo pathway controls tissue growth and homeostasis through a central MST- LATS kinase cascade. The scaffold protein SAV1 promotes the activation of this kinase cascade, but the molecular mechanisms remain unknown. Here, we discover SAV1-mediated inhibition of the PP2A complex STRIPAKSLMAP as a key mechanism of MST1/2 activation. SLMAP binding to autophosphorylated MST2 linker recruits STRIPAK and promotes PP2A-mediated dephosphorylation of MST2 at the activation loop. Our structural and biochemical studies reveal that SAV1 and MST2 heterodimerize through their SARAH domains. Two SAV1–MST2 heterodimers further dimerize through SAV1 WW domains to form a heterotetramer, in which MST2 undergoes trans-autophosphorylation. SAV1 directly binds to STRIPAK and inhibits its phosphatase activity, protecting MST2 activation-loop phosphorylation. Genetic ablation of SLMAP in human cells leads to spontaneous activation of the Hippo pathway and alleviates the need for SAV1 in Hippo signaling. Thus, SAV1 promotes Hippo activation through counteracting the STRIPAKSLMAP PP2A *For correspondence: phosphatase complex. [email protected] DOI: https://doi.org/10.7554/eLife.30278.001 †These authors contributed equally to this work Competing interests: The Introduction authors declare that no The balance between cell division and death maintains tissue homeostasis of multicellular organisms.
    [Show full text]
  • The Roles of Fgfs in the Early Development of Vertebrate Limbs
    Downloaded from genesdev.cshlp.org on September 26, 2021 - Published by Cold Spring Harbor Laboratory Press REVIEW The roles of FGFs in the early development of vertebrate limbs Gail R. Martin1 Department of Anatomy and Program in Developmental Biology, School of Medicine, University of California at San Francisco, San Francisco, California 94143–0452 USA ‘‘Fibroblast growth factor’’ (FGF) was first identified 25 tion of two closely related proteins—acidic FGF and ba- years ago as a mitogenic activity in pituitary extracts sic FGF (now designated FGF1 and FGF2, respectively). (Armelin 1973; Gospodarowicz 1974). This modest ob- With the advent of gene isolation techniques it became servation subsequently led to the identification of a large apparent that the Fgf1 and Fgf2 genes are members of a family of proteins that affect cell proliferation, differen- large family, now known to be comprised of at least 17 tiation, survival, and motility (for review, see Basilico genes, Fgf1–Fgf17, in mammals (see Coulier et al. 1997; and Moscatelli 1992; Baird 1994). Recently, evidence has McWhirter et al. 1997; Hoshikawa et al. 1998; Miyake been accumulating that specific members of the FGF 1998). At least five of these genes are expressed in the family function as key intercellular signaling molecules developing limb (see Table 1). The proteins encoded by in embryogenesis (for review, see Goldfarb 1996). Indeed, the 17 different FGF genes range from 155 to 268 amino it may be no exaggeration to say that, in conjunction acid residues in length, and each contains a conserved with the members of a small number of other signaling ‘‘core’’ sequence of ∼120 amino acids that confers a com- molecule families [including WNT (Parr and McMahon mon tertiary structure and the ability to bind heparin or 1994), Hedgehog (HH) (Hammerschmidt et al.
    [Show full text]
  • Seifert Et Al Fgf8 Dev2009.Pdf
    RESEARCH ARTICLE 2643 Development 136, 2643-2651 (2009) doi:10.1242/dev.036830 Functional and phylogenetic analysis shows that Fgf8 is a marker of genital induction in mammals but is not required for external genital development Ashley W. Seifert1, Terry Yamaguchi2 and Martin J. Cohn1,3,* In mammalian embryos, male and female external genitalia develop from the genital tubercle. Outgrowth of the genital tubercle is maintained by the urethral epithelium, and it has been reported that Fgf8 mediates this activity. To test directly whether Fgf8 is required for external genital development, we conditionally removed Fgf8 from the cloacal/urethral epithelium. Surprisingly, Fgf8 is not necessary for initiation, outgrowth or normal patterning of the external genitalia. In early genital tubercles, we found no redundant Fgf expression in the urethral epithelium, which contrasts with the situation in the apical ectodermal ridge (AER) of the limb. Analysis of Fgf8 pathway activity showed that four putative targets are either absent from early genital tubercles or are not regulated by Fgf8. We therefore examined the distribution of Fgf8 protein and report that, although it is present in the AER, Fgf8 is undetectable in the genital tubercle. Thus, Fgf8 is transcribed, but the signaling pathway is not activated during normal genital development. A phylogenetic survey of amniotes revealed Fgf8 expression in genital tubercles of eutherian and metatherian mammals, but not turtles or alligators, indicating that Fgf8 expression is neither a required nor a conserved feature of amniote external genital development. The results indicate that Fgf8 expression is an early readout of the genital initiation signal rather than the signal itself.
    [Show full text]
  • Fgf8 Induces Heart Development 227
    Development 127, 225-235 (2000) 225 Printed in Great Britain © The Company of Biologists Limited 2000 DEV1488 Induction and differentiation of the zebrafish heart requires fibroblast growth factor 8 (fgf8/acerebellar) Frank Reifers1, Emily C. Walsh2, Sophie Léger1, Didier Y. R. Stainier2 and Michael Brand1,* 1Department of Neurobiology, University of Heidelberg, Im Neuenheimer Feld 364, D-69120 Heidelberg, Germany 2Department of Biochemistry and Biophysics, University of California San Francisco, San Francisco, CA 94143-0554, USA *Author for correspondence (e-mail: [email protected]) Accepted 1 November; published on WWW 20 December 1999 SUMMARY Vertebrate heart development is initiated from bilateral heart ventricle. Fgf8 is required for the earliest stages of lateral plate mesoderm that expresses the Nkx2.5 and nkx2.5 and gata4, but not gata6, expression in cardiac GATA4 transcription factors, but the extracellular signals precursors. Cardiac gene expression is restored in specifying heart precursor gene expression are not known. acerebellar mutant embryos by injecting fgf8 RNA, or by We describe here that the secreted signaling factor Fgf8 is implanting a Fgf8-coated bead into the heart primordium. expressed in and required for development of the zebrafish Pharmacological inhibition of Fgf signalling during heart precursors, particularly during initiation of cardiac formation of the heart primordium phenocopies the gene expression. fgf8 is mutated in acerebellar (ace) acerebellar heart phenotype, confirming that Fgf signaling mutants, and homozygous mutant embryos do not establish is required independently of earlier functions during normal circulation, although vessel formation is only gastrulation. These findings show that fgf8/acerebellar is mildly affected. In contrast, heart development, in required for induction and patterning of myocardial particular of the ventricle, is severely abnormal in precursors.
    [Show full text]
  • Acute Myeloid Leukemia - Biology 2 with Pmscv-NUP98-NSD1-Neo Or Pmscv-FLT3-ITD-GFP Retroviral Vectors Or Both
    Milan, Italy, June 12 – 15, 2014 Methods: Lineage marker-negative murine bone marrow cells were transduced Acute myeloid leukemia - Biology 2 with pMSCV-NUP98-NSD1-neo or pMSCV-FLT3-ITD-GFP retroviral vectors or both. Transduced cells were analyzed for their clonogenic potential by serial plating in growth-factor containing methylcellulose followed by expansion and P142 injection into sublethally irradiated syngeneic recipients. Results: Expression of NUP98-NSD1 provided aberrant self-renewal poten - Abstract withdrawn tial to bone marrow progenitor cells. Co-expression of FLT3-ITD increased proliferation but impaired self-renewal in vitro . Transplantation of cells expressing NUP98-NSD1 and FLT3-ITD into mice resulted in transplantable P143 AML after a short latency. The leukaemic blasts expressed myeloid markers + + + lo lo THE CAMP RESPONSE ELEMENT BINDING PROTEIN (CREB) OVEREX - (Mac-1 /Gr-1 /Fc γRII/III /c-kit /CD34 ). Splinkerette-PCR revealed similar PRESSION INDUCES MYELOID TRANSFORMATION IN ZEBRAFISH patterns of potential retroviral integration sites of in vitro immortalized bone C Tregnago 1,* V Bisio 1, E Manara 2, S Aveic 1, C Borga 1, S Bresolin 1, G Germano 2, marrow cells before and after expansion in vivo . Mice that received cells G Basso 1, M Pigazzi 2 expressing solely NUP98-NSD1 did not develop AML but showed signs of a 1Dipartimento di salute della donna e del bambino, Università degli Studi di myeloid hyperplasia after long latency, characterized by expansion of Mac- Padova, 2Dipartimento di salute della donna e del bambino, IRP, Padova, Italy 1+/Gr-1 + cells in the bone marrow and active extramedullary haematopoiesis in the spleen.
    [Show full text]